Company news

Qtrex Quantum Ltd. (NASDAQ:QTEX) news

Qtrex Quantum Ltd. news releases on 6ix. Latest, Oct 1, 2026: QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company…

Qtrex Quantum Ltd. (NASDAQ:QTEX) news

Press releases & updates

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader

QTREX Quantum Reports First Half 2026 Financial Results

One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology

QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026

QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

QTREX Announces Clarification to Registration Statement on Form F-1

QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

QTREX Announces Management Share Purchase Plan

QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier

QTREX Quantum’s AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston

QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials

QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension

Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform

Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment

Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use